Icad Inc Stock Investor Sentiment

ICAD Stock  USD 2.41  0.02  0.84%   
About 68 percent of all Icad's shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding icad inc suggests that quite a large number of traders are confidant. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
17 hours ago at www.macroaxis.com         
Acquisition by Wood Susan Alyson of 10593 shares of Icad at 3.69 subject to Rule 16b-3
Macroaxis News
3 days ago at finance.yahoo.com         
iCAD, Inc. and Koios Partner to Enhance AI-Powered Breast Cancer Detection
Yahoo News
few days ago at globenewswire.com         
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solution...
Macroaxis News: globenewswire.com
few days ago at gurufocus.com         
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Acquisition by Eric Lonnqvist of 15833 shares of Icad subject to Rule 16b-3
Yahoo News
over a week ago at finance.yahoo.com         
iCAD, Inc. to Showcase AI-Powered Breast Health Innovations at ECR 2025
Yahoo News
over a week ago at finance.yahoo.com         
iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Eval...
Yahoo News
over a week ago at gurufocus.com         
iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk ...
Gurufocus Stories at Macroaxis
over two weeks ago at news.google.com         
117,000 Shares in iCAD, Inc. Acquired by Summit Trail Advisors LLC - MarketBeat
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
iCAD Downgraded to Sell Rating by StockNews.com
news
over three weeks ago at www.macroaxis.com         
Acquisition by Patel Rakesh of 8575 shares of Icad at 3.69 subject to Rule 16b-3
Macroaxis News
over three weeks ago at insidermonkey.com         
Why iCAD Inc Is Skyrocketing So Far In 2025
insidermonkey News
over three weeks ago at finance.yahoo.com         
Why iCAD Inc Is Skyrocketing So Far In 2025
Yahoo News
over three weeks ago at news.google.com         
Why iCAD Inc Is Skyrocketing So Far In 2025 - Yahoo Finance
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
iCAD, Inc. Pre-Announces Estimated Q4 2024 Revenue
news
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Icad Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium
12/12/2024
2
iCAD Stock Crosses Above 200 Day Moving Average Should You Sell
01/03/2025
3
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
01/15/2025
4
Barfresh Food Group And 2 Other US Penny Stocks To Watch
01/23/2025
5
After Leaping 46 percent iCAD, Inc. Shares Are Not Flying Under The Radar - Simply Wall St
01/28/2025
6
Why iCAD Inc Is Skyrocketing So Far In 2025 - Yahoo Finance
02/03/2025
7
Acquisition by Patel Rakesh of 8575 shares of Icad at 3.69 subject to Rule 16b-3
02/05/2025
8
iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk ...
02/19/2025
9
Acquisition by Eric Lonnqvist of 15833 shares of Icad subject to Rule 16b-3
02/21/2025
10
iCAD, Inc. and Koios Partner to Enhance AI-Powered Breast Cancer Detection
02/27/2025

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal